Gene · 6708
NIH grants1,200
NIH grants whose papers are about the gene, through NIH's grant-paper links.
221 to 240 of 1,200
Download this page as JSON| Grant | Title | SPTA1 papers | Newest fiscal year |
|---|---|---|---|
| R35HG011324 | Mapping enhancer-gene regulation in single cells to connect genetic variants to target genes and cell types | 1 | 2024 |
| T32CA009666 | Research Training in Academic Medical Oncology | 1 | 2024 |
| T32HL007910 | Basic Sciences Studies on Gene Therapy of Blood Diseases | 1 | 2024 |
| U01CA200147 | The second phase of NIH Common Fund 4D Nucleome Network Organizational Hub | 1 | 2024 |
| U24CA248453 | Comprehensive and Robust Tools for Analysis of Tumor Heterogeneity and Evolution | 1 | 2024 |
| U24MH068457 | Limited Competition: Continuation of the Center for Genomic Studies on Mental Disorders | 1 | 2024 |
| ZIAAG000932 | Characterization of Normal Genomic Variability | 1 | 2024 |
| R01HL149714 | Interactions between the ADORA2b/Sphk1axis and the AE1-Hb switch in red blood cell aging in vivo and in vitro | 5 | 2023 |
| RM1GM131968 | Resuscitation Strategies for Achieving Thrombo-inflammatory Homeostasis | 4 | 2023 |
| T34GM008563 | MARC U*STAR Program at the University of California, Los Angeles | 2 | 2023 |
| U24GM129547 | Pacific Northwest Center for Cryo-EM | 2 | 2023 |
| K08CA237871 | The roles of anti-apoptotic proteins BCL-XL and MCL1 in mediating survival of high-grade serous ovarian cancer following drug-induced DNA damage | 1 | 2023 |
| P20GM104360 | Center of Biomedical Research Excellence, Epigenomics of Development and Disease | 1 | 2023 |
| R00HD092613 | Discovery and characterization of novel ciliopathy protein complexes | 1 | 2023 |
| R00HD097286 | Integrative analysis of human placental epi/genome in relation to fetal growth | 1 | 2023 |
| R01CA231011 | Development of Long non-coding RNA-directed Target Therapy for Triple-Negative Breast Cancer | 1 | 2023 |
| R01CA234629 | The molecular and immune evolution in the progression of lung neoplasia to invasive adenocarcinoma | 1 | 2023 |
| R01CA240526 | INVESTIGATING TUMOR INITIATION AND INVASION IN PREMALIGNANT BREAST CANCER WITH SPATIAL SINGLE CELL GENOMICS | 1 | 2023 |
| R01DK058044 | Epigenetic Control of Hematopoietic Gene Expression | 1 | 2023 |
| R01ES015869 | Translesion synthesis DNA polymerases and genome instability | 1 | 2023 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6708/grants?page=12